ELENA LEVY: Open Payments
NPI 1629179569 · FRESH MEADOWS, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,221 in 38 payments from 9 companies in 2025. Trend: 2023 $748 · 2024 $1,196 · 2025 $1,221
Food & beverage: $1,221
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $461 |
| Regeneron Healthcare Solutions, Inc. | 6 | $346 |
| ARS Pharmaceuticals Operations, Inc. | 6 | $145 |
| Optinose US, Inc. | 4 | $98 |
| Novartis Pharmaceuticals Corporation | 2 | $68 |
| Grifols USA, LLC | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $28 |
| ALK-Abello, Inc | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
Products named: DUPIXENT, NEFFY, Xhance, Rhapsido, Xembify, NUCALA, Odactra, VOQUEZNA.
Industry payments across NY — which companies pay providers there.
